Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DEXTROSE INJECTION - Health Canada Drug Approval Details

Approvals/Health Canada/DEXTROSE INJECTION

Authorized

STANDARD

DEXTROSE INJECTION

omega laboratories limited🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 9ad3df5dfbeea2eb
Company: omega laboratories limited
Type: Standard

Approval Details

Approval Id: 9ad3df5dfbeea2eb
Drug Approval Canada Name: DEXTROSE INJECTION
Product Name: DEXTROSE INJECTION
Status: Marketed
Status Date: 2022-03-30
Original Market Date: 2022-03-30
Din: 02517132
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 40:20.00
Atc Original: B05BA03 CARBOHYDRATES
Atc Name: b 05 ba 03
Aig Number: 0102181001
Company Name: omega laboratories limited
Company Address: 11177 Hamon, Montreal, Quebec, Canada, H3M 3E4

Active Ingredients

DEXTROSE

50 % / W/V

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9ad3df5dfbeea2eb

Type

Standard

Back to Health Canada Approvals